Vision 20 vs OptiPlax: a carotenoid formula against a marine blend
After 50 Strong reviewed both products separately, and the comparison practically writes itself. Vision 20 discloses doses for its key ingredients and, in some label versions, matches the AREDS2 carotenoid doses exactly. OptiPlax names five marine ingredients and publishes none of their amounts. Vision 20 carries a 180-day guarantee; OptiPlax, 60 days with more conditions. OptiPlax is fourteen cents cheaper per day at reported bundle prices. Here is the side-by-side, the category winners, and what the difference actually buys you.
- Transparency winner: Vision 20. Key doses disclosed, including the AREDS2 pair at 10 mg and 2 mg in some versions. OptiPlax: zero milligrams published.
- Evidence concept: Vision 20 points at AREDS2 research; OptiPlax’s astaxanthin has real eye-fatigue trials at 6 to 12 mg that its blend cannot be verified against.
- Price per day: OptiPlax 1 dollar 63 cents, Vision 20 1 dollar 77 cents, both at reported prices and both needing checkout verification.
- Guarantee: Vision 20’s 180 days beats OptiPlax’s 60 days from delivery with bottle-and-packing-slip conditions.
The two products in brief
Vision 20, from Zenith Labs, is a one-capsule daily formula built on a branded lutein-plus-zeaxanthin complex with zinc citrate, wrapped in botanicals including ginkgo biloba, plus vitamins A, C and E depending on the version. It sells on its own site at 53 dollars and 10 cents per bottle on a subscription, with a 180-day guarantee. Our full Vision 20 review scored it 2.8 out of 5.
OptiPlax is a one-capsule daily proprietary blend of five marine ingredients: astaxanthin, chlorella, kelp, wakame and Ecklonia cava, sold through its own site with a standard third-party retailer of record at a reported 49 dollars per bottle in the six-bottle package, with a 60-day guarantee. Our full OptiPlax review scored it 2.1 out of 5, held back by the undisclosed doses and a plaque-cleansing mechanism that human research does not support.
Side by side: ten rows that matter
| Category | Vision 20 | OptiPlax |
|---|---|---|
| Maker | Zenith Labs, established supplement company | Own brand storefront, third-party retailer of record |
| Formula type | Carotenoid core plus zinc, botanicals, vitamins | Five-ingredient marine blend |
| Label transparency | Key doses disclosed; versions conflict on some numbers | Zero milligrams disclosed, proprietary blend |
| AREDS2 match | Carotenoid pair at studied doses in some versions | No standalone lutein or zeaxanthin |
| Headline ingredient evidence | Lutein and zeaxanthin, AREDS2, 4,203 participants | Astaxanthin, small eye-fatigue trials at 6 to 12 mg |
| Price per day | 1 dollar 77 cents at the listed subscription price | 1 dollar 63 cents at the reported six-bottle price |
| Guarantee | 180 days, stated on the official site | 60 days from delivery, all bottles plus packing slip |
| Main interaction flag | Ginkgo biloba against blood thinners | Iodine-rich algae against thyroid medication |
| Central marketing claim | Supports near, far and low-light vision, overstated | Cleanses plaque from eye tissues, unsupported |
| Our score | 2.8 out of 5 | 2.1 out of 5 |
Where Vision 20 wins
The dose line. Being able to read lutein 10 mg and zeaxanthin 2 mg on a label, and knowing those are the amounts AREDS2 tested in 4,203 participants, is the entire foundation of informed buying in this category. Vision 20 gives you that on its key actives, with a zinc caveat worth checking on your bottle. OptiPlax gives you five names and a proprietary blend, which means its best ingredient, astaxanthin, could be present at a studied 6 to 12 mg or at trace amounts, and no one outside the company knows. The 180-day guarantee tells the same story from the consumer-protection side: three times the window, fewer conditions.
Where OptiPlax wins
Price and purchase mechanics, narrowly. Fourteen cents per day cheaper at reported bundle prices, a one-off purchase with no subscription to manage, and free shipping on larger packages. If money and simplicity are your only criteria, OptiPlax takes the category. The honest counterweight is what those fourteen cents buy: a label you can audit, a guarantee three times as long, and a formula whose central claims at least gesture toward real trials rather than a plaque-cleansing mechanism human research has never observed.
The verdict on evidence and value
Evidence. Vision 20 wins by default and on the merits: its core ingredients point at the largest eye-nutrition trial ever run, even if the finished formula borrows that credibility. OptiPlax points at real astaxanthin trials its own label cannot be measured against. Neither product has a formula-level trial.
Value. OptiPlax is cheaper per day; Vision 20 is worth more per dollar because a disclosed dose is the thing you are actually buying. Our scores say the same thing from two directions: 2.8 out of 5 versus 2.1 out of 5.
Bottom line. Two differently flawed products, one clear documentation gap between them. If you are choosing inside this pair, choose the label you can read, then verify it against your medications and your actual eye health, which starts at our eye health hub. If an eye specialist has already spoken, their formula beats both of these.
Frequently Asked Questions
Which is better, Vision 20 or OptiPlax?
Vision 20 wins on the categories that matter most, with caveats. It discloses doses for its key ingredients and, in versions listing lutein 10 mg plus zeaxanthin 2 mg, matches the AREDS2 doses tested in 4,203 participants with macular degeneration. OptiPlax names five marine ingredients but publishes zero milligram amounts, so its one well-researched ingredient, astaxanthin, cannot be compared to the 6 to 12 mg used in human eye-fatigue trials. OptiPlax is slightly cheaper per day at the reported bundle price. Our scores: 2.8 out of 5 for Vision 20, 2.1 for OptiPlax.
Can I take Vision 20 and OptiPlax together?
We would not, and the reason is arithmetic you cannot do. OptiPlax does not disclose its doses, so stacking it with Vision 20 makes total carotenoid and mineral intake unknowable. What is knowable points the same way: both formulas carry vitamin A and E in unconfirmed amounts, which risks duplication past sensible daily totals, and each product has its own interaction flag, ginkgo against blood thinners in Vision 20, iodine-rich algae against thyroid medication in OptiPlax. One formula at a time, verified against your medication list, is the defensible approach.
Which is closer to the AREDS2 formula?
Vision 20, and only partially. AREDS2 tested a specific combination: vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg, copper 2 mg, plus lutein 10 mg and zeaxanthin 2 mg in 4,203 participants with age-related macular degeneration. Vision 20 carries the carotenoid pair at the studied doses in some versions but not the vitamin-mineral base. OptiPlax contains no standalone lutein or zeaxanthin at all; its chlorella contributes naturally occurring lutein at undisclosed amounts. Neither product is AREDS2. If an eye specialist recommended AREDS2 for diagnosed macular degeneration, take the formula specified, not either of these.
Which is cheaper per day?
OptiPlax, at the reported bundle price. Vision 20 lists at 53 dollars and 10 cents per bottle on its subscription, one capsule a day, which works out to 1 dollar and 77 cents per day. OptiPlax’s six-bottle package reports 49 dollars per bottle, also one capsule a day, which works out to 1 dollar and 63 cents per day. Both figures need verifying at checkout, and the fourteen-cent difference buys the difference between a partially auditable label and an undisclosed blend. Price is the one category OptiPlax wins; value is a different calculation.
Which has the better money-back guarantee?
Vision 20, clearly. Its official site states a 180-day money-back guarantee, one of the longest in the eye supplement category. OptiPlax states 60 days from the delivery date, requires all bottles including empties returned with the packing slip, and leaves return shipping to the buyer. A longer window with a written process beats a shorter one with more conditions, provided you do the paperwork: save the guarantee page, keep every bottle, and contact support inside the window.
Who should avoid both Vision 20 and OptiPlax?
Three groups cover both products at once. Anyone with a diagnosed eye condition such as glaucoma, macular degeneration or diabetic retinopathy, because neither formula treats disease and both compete with real care for attention. Smokers and former smokers, who should avoid beta-carotene wherever it appears and should only use carotenoid formulas cleared by their eye doctor. And anyone on a medication list they have not cross-checked: blood thinners make Vision 20’s ginkgo a doctor conversation, thyroid medication makes OptiPlax’s kelp and wakame one, and undisclosed doses make everything else unquantifiable. New or changing vision belongs in an exam chair before it belongs in a comparison like this one.
